Brami Raises $33M Series B to Expand High‑protein Lupini Bean Pasta

Why It Matters

The funding accelerates Brami’s ability to meet surging consumer demand for whole‑food, plant‑based protein amid rising health concerns over ultra‑processed foods and GLP‑1‑driven protein prioritization. Its retail expansion could reshape the pasta category, challenging incumbents like Barilla.

Key Takeaways

• Brami raised $33M Series B led by VMG Partners.
• Lupini bean pasta offers 21g protein, 9g fiber per 100g.
• Sales surged 440% to $14.7M in 2025.
• Expanding into Walmart, Kroger, Costco, Target, 4,000+ stores.
• Matches consumer shift away from ultra‑processed foods.

Pulse Analysis

Brami’s recent financing underscores the growing appetite for plant‑based proteins that don’t rely on isolates or extensive processing. By leveraging lupini beans—a legume with the highest protein‑to‑calorie ratio of any crop—Brami creates a pasta that combines the familiar texture of durum wheat with a nutrient profile that rivals meat alternatives. The beans’ natural nitrogen‑fixing properties also make the supply chain more sustainable, appealing to environmentally conscious shoppers and investors alike.

Health trends are converging on Brami’s value proposition. Americans are increasingly wary of ultra‑processed foods, with 72% actively avoiding them, while 57% now prioritize protein intake, a shift amplified by the rise of GLP‑1 medications that heighten protein needs. Brami’s two‑ingredient formula—durum wheat semolina and lupini flour—delivers a clean label that satisfies both the anti‑UPF sentiment and the protein‑maximizing mindset, positioning the brand at the nexus of two powerful consumer currents.

The $33 million infusion will fund product diversification, supply‑chain fortification in Italy, and a nationwide retail push. Entry into Walmart and expanded presence at Kroger, Costco, Whole Foods, and Target will give Brami access to over 4,000 points of sale, dramatically increasing shelf visibility. Analysts expect the brand to sustain double‑digit growth, potentially reshaping the pasta aisle and pressuring legacy manufacturers to innovate or partner with similar high‑protein, low‑process offerings. The combination of robust funding, strategic retail partnerships, and alignment with health trends positions Brami as a transformative force in a traditionally static category.

Deal Summary

US plant‑based pasta maker Brami announced a $33 million Series B round led by VM G Partners. The funding will be used to launch new pasta shapes, broaden retail distribution across Walmart, Kroger, Costco, Whole Foods and Target, and strengthen its Italy‑based supply chain.